Skip to content

Viatris VTRS Return on equity

Return on equity at other companies

Pfizer logo
PfizerPFE
10.6%
Cencora logo
CencoraCOR
130.6%-99.8pp
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
19.1%+1.7pp
Roivant Sciences logo
Roivant SciencesROIV
-17.1%-17.7pp
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
22.5%+10.1pp
Biogen logo
BiogenBIIB
8%-1.2pp

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Gross profit$1.2B-0.3%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%
Total assets$36.8B-4.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Market cap$18.32B+49.6%
Enterprise value$31.13B+17.7%
P/S1.3×+0.4×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%
Net margin-2%-1.0pp

Returns & leverage

See full
Debt / equity+0.1×
Current ratio1.6×-0.1×

Where this comes from

Calculated from Viatris’s reported figures.

Based on trailing twelve months.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viatris's return on equity?
Viatris (VTRS) reported return on equity of -2% in Q1 2026.
How has Viatris's return on equity changed year-over-year?
Viatris's return on equity increased by 90.8% year-over-year, from -21.3% to -2%.
What does return on equity mean?
How much profit the company earns on the money shareholders have invested.
How do you interpret return on equity?
Higher is better, but very high ROE can be manufactured by leverage — a thin equity base inflates the ratio. Read it next to debt-to-equity and ROIC to tell genuine returns from balance-sheet engineering.
How does return on equity compare across companies?
Comparable across peers, with the leverage caveat. Negative or near-zero equity makes ROE meaningless, so it is suppressed there.